Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BID | P55957 | 3/20 | 0.54 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.54 |
| ▸ | PPARA | Q07869 | 3/20 | 0.54 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.54 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.54 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.54 |
| ▸ | PPARG | P37231 | 2/20 | 0.54 |
| ▸ | EP300 | Q09472 | 1/20 | 0.54 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.54 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.54 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.54 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.54 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7078027 | 1.00 | BID (0.54) | BIDMCL1PPARABCL2L1BAK1 | |
| SCHEMBL10592243 | 1.00 | BID (0.54) | BIDMCL1PPARABCL2L1BAK1 | |
| SCHEMBL2049435 | 1.00 | BID (0.54) | BIDMCL1PPARABCL2L1BAK1 | |
| SCHEMBL2374613 | 1.00 | BID (0.54) | BIDMCL1PPARABCL2L1BAK1 | |
| SCHEMBL11868801 | 1.00 | BID (0.54) | BIDMCL1PPARABCL2L1BAK1 | |
| SCHEMBL368881 | 0.97 | BID (0.50) | BIDMCL1PPARABCL2L1BAK1 | |
| SCHEMBL11561381 | 0.96 | BID (0.52) | BIDMCL1PPARABCL2L1BAK1 | |
| SCHEMBL25420946 | 0.94 | PTPN11 (0.50) | BIDMCL1PPARABCL2L1BAK1 | |
| SCHEMBL10522498 | 0.94 | PLK1 (0.51) | BIDMCL1PPARABCL2L1BAK1 | |
| SCHEMBL22588815 | 0.91 | BID (0.54) | BIDMCL1PPARABCL2L1BAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119259678-A | Preparation method of titanium belt for composite titanium pot | 新疆湘润新材料科技有限公司 | 2025-01-07 | — | — | CN | claimed |
| EP-2356972-B1 | Method and kits for improving comfort of the intimate area | JOHNSON & JOHNSON CONSUMER INC (US) | 2016-04-20 | — | — | EP | claimed |
| EP-2356971-B1 | Compositions for repelling fluid and uses thereof | JOHNSON & JOHNSON CONSUMER INC (US) | 2016-04-20 | — | — | EP | claimed |
| CN-119259678-A | Preparation method of titanium belt for composite titanium pot | 新疆湘润新材料科技有限公司 | 2025-01-07 | — | — | CN | disclosed |
| EP-1644053-B9 | Skin friendly single-use product | HARTMANN PAUL AG (DE) | 2014-09-10 | — | — | EP | disclosed |
| EP-1644053-B1 | Skin friendly single-use product | HARTMANN PAUL AG (DE) | 2014-06-18 | — | — | EP | disclosed |
| EP-2654665-A2 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH (DE) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012083906-A2 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA PHARMA GESELLSCHAFT FÜR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) | 2012-06-28 | — | — | WO | disclosed |
| US-20070092462-A1 | Cosmetic compositions | CITICORP USA, INC. | 2007-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070092462-A1 | Cosmetic compositions | PLOD3, COL14A1, COL2A1 | BID 4140/4885MCL1 3339/4885PPARA 398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.